Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
The American Journal of Medicine
|
December 3, 2014
Risk of cancer in patients with cholecystitis: a nationwide population-based study
Pei-Chang Lee, Yu-Wen Hu, Li-Yu Hu, et al.
Journal of Hepatocellular Carcinoma
|
December 1, 2025
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
Chien-Hung Lu, Ching-Wen Chang, San-Chi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2022
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong, et al.
The Oncologist
|
November 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancer
Wen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu, et al.
Liver Cancer
|
July 21, 2025
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation
Ming Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
Liver Cancer
|
October 22, 2024
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression
Tsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, et al.
Hepatology International
|
February 24, 2026
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablation
Ching-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, et al.
Journal of Hepatology
|
September 19, 2025
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
Yih-Jyh Lin, Da-Liang Ou, Yung-Yeh Su, et al.
Liver Cancer
|
April 21, 2025
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
Choong-Kun Lee, Changhoon Yoo, Jung Yong Hong, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
The American Journal of Medicine
|
December 3, 2014
Risk of cancer in patients with cholecystitis: a nationwide population-based study
Pei-Chang Lee, Yu-Wen Hu, Li-Yu Hu, et al.
Journal of Hepatocellular Carcinoma
|
December 1, 2025
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
Chien-Hung Lu, Ching-Wen Chang, San-Chi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2022
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong, et al.
The Oncologist
|
November 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancer
Wen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu, et al.
Liver Cancer
|
July 21, 2025
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation
Ming Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
Liver Cancer
|
October 22, 2024
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression
Tsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, et al.
Hepatology International
|
February 24, 2026
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablation
Ching-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, et al.
Journal of Hepatology
|
September 19, 2025
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
Yih-Jyh Lin, Da-Liang Ou, Yung-Yeh Su, et al.
Liver Cancer
|
April 21, 2025
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
Choong-Kun Lee, Changhoon Yoo, Jung Yong Hong, et al.
Page
of 7